Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate

Published:2010-07-06 Issue:6 Volume:28 Page:713-718
ISSN:0914-8779
Container-title:Journal of Bone and Mineral Metabolism
language:en
Short-container-title:J Bone Miner Metab

Author:

Yang Kyu-Hyun,Park Si-Young,Park Sang-Won,Lee Soon-Hyuck,Han Seung-Beom,Jung Woong-Kyo,Kim Suk-Jin

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00774-010-0203-2.pdf

Reference24 articles.

1. Savage DG, Antman KH (2002) Imatinib mesylate: a new oral targeted therapy. N Engl J Med 346:683–693

2. Druker BJ (2004) Imatinib as a paradigm of targeted therapies. Adv Cancer Res 91:1–30

3. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031–1037

4. Berman E, Nicolaides M, Maki RG, Fleisher M, Chanel S, Scheu K, Wilson BA, Heller G, Sauter NP (2006) Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med 354:2006–2013

5. Grey A, O’Sullivan S, Reid IR, Browett P (2006) Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism. N Engl J Med 355:2494–2495

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Nanomechanical Properties and Relationship to Bone Turnover and Architecture in Patients With Atypical Femur Fractures: A Prospective Nested Case‐Control Study;JBMR Plus;2021-08-12

2. Side Effects and Sequelae of Treatment for Chronic Myeloid Leukemia in Childhood and Adolescence;Late Treatment Effects and Cancer Survivor Care in the Young;2020-11-06

3. Imatinib-induced bone oedema mimicking Type 1 complex regional pain syndrome;Rheumatology;2019-10-19

4. Osteopenia and fractures associated with long-term therapy with MEK inhibitors;Melanoma Research;2018-12

5. Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies;Endocrine-Related Cancer;2014-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3